{"filings":[{"id":2364757,"accession_number":"0001079973-26-001153","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2026-08-20T12:03:24+00:00","items":["7.01","9.01"],"status":"ready","headline":"CDIO investor deck: CMS $854/test rate set; Atlas coverage; Dr. Lal PathLabs India deal; lab scale-up","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CMS final payment rate of $854 per test set (Dec 2025) for both Epi+Gen CHD (0439U) and PrecisionCHD (0440U) CPT codes.","Atlas Healthcare Physicians began in-network coverage with prior authorization (June 2026); out-of-network billing launched July 2026.","Dr. Lal PathLabs (290+ labs, 300+ pathologists) to offer PrecisionCHD in India; Aimil Ltd partnership extends distribution network.","Company-owned CLIA lab now processing tests in-house, cutting initial COGS ~30%; turnaround time 7-10 business days.","Combined US TAM ~$175B: 146M eligible for Epi+Gen CHD risk test, 60M for PrecisionCHD diagnostic; 40% gross margin target at scale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110326,"accession_number":"0001079973-26-000239","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics holds investor call; highlights $854 CMS rate, new CLIA lab, and India expansion","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Investor presentation reveals $854 final CMS gapfill rate for both Epi+Gen CHD and PrecisionCHD tests.","New internal CLIA lab reduces initial COGS by ~30%; further reductions expected at scale.","TAM estimated at ~$176B across both tests, with 146M and 60M eligible Americans respectively.","Announced partnership with Aimil Ltd and Dr. Lal PathLabs for India expansion of PrecisionCHD.","Preliminary data on PrecisionCHD presented at AHA and ACC conferences showing INOCA detection and ACS mortality prediction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126925,"accession_number":"0001079973-25-001612","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2025-10-15T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Shareholders approve 20%+ share issuance authority, elect 7 directors at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected 7 directors: Dogan, Hosseinion, Betts, Burton, Fung, Intrater, Philibert each with over 355K votes for.","Proposal to allow future issuance of shares ≥20% of outstanding common stock passed (283,304 for; 166,492 against).","Ratified Prager Metis CPA's LLC as auditor for FY 2025 (813,401 for; 64,820 against; 49,305 abstain).","Total 927,526 shares voted (52.6% of eligible) as of record date August 25, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161938,"accession_number":"0001079973-25-000937","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cardio Diagnostics regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On May 28, 2025, Nasdaq confirmed compliance after closing bid price ≥$1.00 for 10 consecutive business days (May 13-27, 2025).","Company had been under minimum bid price non-compliance notice since June 2024, with extended deadline of June 2, 2025.","Regained compliance ensures continued listing on Nasdaq Capital Market under Listing Rule 5550(a)(2)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161937,"accession_number":"0001079973-25-000781","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["3.03","5.03","7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics announces 1-for-30 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reverse split at 1:30, effective after close May 12; trading begins May 13 under CDIO.","Outstanding shares reduced from ~52M to ~1.7M; authorized shares remain 300M.","New CUSIP 14159C202; fractional shares rounded up/down by DTC.","Split approved by shareholders Nov 15, 2024; Board set ratio on April 10, 2025.","Split adjusts warrants, options, and equity plan shares proportionately."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179999,"accession_number":"0001079973-25-000308","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics provides investor presentation; no material new facts disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company filed an Investor Presentation dated February 2025 under Item 7.01.","Presentation focuses on epigenetics and AI for cardiovascular medicine but contains no specific financial or operational metrics.","No changes to guidance, revenue, EPS, or business outlook were reported.","Presentation is available on the company's website for investor use."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196792,"accession_number":"0001079973-24-001660","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cardio Diagnostics gets second Nasdaq extension to June 2, 2025 for bid price rule; may reverse split","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Second Nasdaq letter grants 180-day extension until June 2, 2025, to meet $1.00 minimum bid price.","Common stock (CDIO) and warrants (CDIOW) continue trading; no immediate delisting effect.","Company will consider a reverse stock split, must complete it 10 business days before deadline.","If not compliant by end of extension, Nasdaq will issue delisting notice; company may appeal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196791,"accession_number":"0001079973-24-001569","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cardio Diagnostics shareholders elect seven directors and approve reverse stock split authorization up to 1:40","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected: Dogan, Philibert, Burton, Hosseinion, Intrater, Betts, Fung.","Reverse stock split proposal approved (range 1:5 to 1:40) at board discretion within one year; 9,825,603 for, 4,015,095 against.","Proposal to issue 20%+ of common stock in non-public transactions passed; 5,617,556 for, 2,118,676 against, 6,014,546 broker non-votes.","Ratification of Prager Metis CPAs LLC as independent auditor for FY2024 approved with 12,010,406 for, 947,141 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232206,"accession_number":"0001079973-24-000850","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cardio Diagnostics receives Nasdaq bid price deficiency notice; 180-day cure period until Dec 2, 2024","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on June 3, 2024 for non-compliance with minimum bid price rule (below $1.00 for 30 consecutive days).","Has 180 calendar days, until December 2, 2024, to regain compliance by closing at $1.00+ for 10 consecutive business days.","If not compliant by Dec 2, may be eligible for additional 180-day period if other listing standards are met.","Company may consider reverse stock split to cure deficiency; no assurance of regaining compliance.","Notice has no immediate effect on listing or trading of common stock or warrants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232205,"accession_number":"0001079973-24-000500","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics releases March 2024 investor presentation for use with investors","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor presentation becomes effective April 3, 2024.","Presentation is available on the company's website and will be used in meetings.","No specific financial or operational updates are disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250481,"accession_number":"0001079973-24-000172","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-02-02T23:59:59+00:00","items":["3.02","8.01","9.01"],"status":"ready","headline":"Cardio Diagnostics raises $1M via private placement of 561,793 units (stock + warrants) at $1.78/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $1,000,000 from sale of 561,793 units to 7 accredited investors at $1.78 per unit.","Each unit includes one share of common stock and a six-year warrant exercisable at $1.78 per share.","Placement agent Altitude Capital received 10% cash commission plus 112,353 warrant coverage at $1.78 through Feb 2030.","Chairman Warren Hosseinion, M.D., holds 10% ownership in Altitude Capital; recused from board approval.","Net proceeds to be used for working capital and general corporate purposes; resale registration planned within 180 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250480,"accession_number":"0001079973-24-000169","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Cardio Diagnostics enters $17M at-the-market equity offering with Craig-Hallum","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Up to $17M in common stock may be sold via Craig-Hallum as sales agent under an ATM offering.","Craig-Hallum will receive 2.5% commission on gross proceeds; legal fee reimbursement up to $55,000.","Proceeds to be used for general corporate purposes, including working capital and capex.","Registration statement on Form S-3 declared effective by SEC on February 1, 2024.","Sales may be made on Nasdaq Capital Market through ordinary brokers' transactions or negotiated deals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250479,"accession_number":"0001079973-24-000021","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2024-01-04T23:59:59+00:00","items":["1.02","9.01"],"status":"ready","headline":"Cardio Diagnostics terminates $11.2M convertible debenture agreement with Yorkville","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mutual termination of Securities Purchase Agreement effective Jan 4, 2024; no fees or penalties due.","First $5.0M debenture (issued for $4.5M) had been fully repaid before termination.","Second $6.2M debenture ($5.58M purchase price) was never issued; conditions remained unsatisfied.","No outstanding borrowings, advance notices, or shares to be issued under the agreement at termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268036,"accession_number":"0001079973-23-001784","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-12-19T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cardio Diagnostics shareholders approve reverse stock split, share issuance, and board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected; each received >5.8M for, <0.4M withheld, 3.48M broker non-votes.","Reverse stock split of 1:5 to 1:40 approved (7.42M for, 2.25M against); board may implement within one year.","Share issuance proposal for transactions resulting in 20%+ dilution approved (5.01M for, 1.16M against).","Ratification of Prager Metis CPAs as auditor for FY2023 approved (9.07M for, 0.59M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268035,"accession_number":"0001079973-23-001705","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-12-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cardio Diagnostics regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received Nasdaq notice on Dec 5, 2023 confirming compliance with minimum bid price rule.","Closing bid price at $1.00+ for 10 consecutive business days (Nov 20 – Dec 4, 2023).","Prior non-compliance notice from Sep 21, 2023 for bid price below $1.00 for 30 days.","Nasdaq considers the matter closed; no further action needed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268034,"accession_number":"0001079973-23-001650","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-11-22T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cardio Diagnostics receives Nasdaq equity deficiency notice; claims cure via Yorkville conversion","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified CDIO on Nov 20, 2023 of non-compliance with $2.5M minimum stockholders' equity requirement.","Reported equity of $2,287,731 as of Sep 30, 2023, below the required threshold.","Yorkville fully converted debentures on Oct 31, 2023, raising equity to $4,044,689; company asserts compliance regained.","Nasdaq will monitor; failure in next periodic report could trigger delisting. Company exploring financing options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285271,"accession_number":"0001079973-23-001304","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-09-25T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cardio Diagnostics receives Nasdaq minimum bid price deficiency notice","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Sept 21, 2023 for common stock bid price below $1.00 for 30 consecutive business days.","Company has 180 calendar days, until March 19, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.","If non-compliant by deadline, may qualify for an additional 180-day period if other listing standards met.","Company considering options including stockholder approval for a reverse stock split to cure deficiency.","Trading of common stock and warrants on Nasdaq continues unaffected during the cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285269,"accession_number":"0001079973-23-001267","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K/A","filed_at":"2023-09-14T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Cardio Diagnostics extends Yorkville second closing to Dec 2023; lowers floor price to $0.20","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second closing deadline extended to December 29, 2023 from September 15, 2023, subject to conditions.","Floor price for convertible debentures reduced from $0.55 to $0.20 per share, effective retroactively.","Share issuance cap set at 20,363,637 shares; stockholder approval or legal opinion required to exceed.","Nasdaq minimum bid price notice no longer constitutes a condition failure unless it immediately affects listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285270,"accession_number":"0001079973-23-001248","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-09-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics posts investor presentation; no specific updates disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Senior management will use the new investor presentation starting September 11, 2023.","Presentation is available on the company's website at www.cardiodiagnosticsinc.com.","No financial results, guidance, or material business changes were announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305116,"accession_number":"0001553350-23-000338","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Cardio Diagnostics enters director agreements with four independent directors; $50K annual RSU retainer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Agreements with James Intrater, Stanley Lau, Oded Levy, and Brandon Sim, effective June 19, 2023.","Annual retainer of $50,000 paid in restricted stock units; 2023 vesting: $25K on June 30, $12.5K on Sept 30, $12.5K on Dec 31.","Directors also receive $500 per diem for out-of-town travel and expense reimbursement.","Agreement includes standard confidentiality and indemnification provisions.","Agreement auto-renews upon reelection unless Board decides otherwise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305113,"accession_number":"0001079973-23-000822","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K/A","filed_at":"2023-06-05T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Cardio Diagnostics amends SPA with Yorkville, extends second closing to Sept 15, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment delays second closing of $6.2M convertible debenture from prior date to September 15, 2023.","Purchase price remains $5.58M (90% of principal); conditions per SPA Sections 6 and 7 must be met.","No other changes to the securities purchase agreement or the first $5M debenture terms.","Yorkville is a fund managed by Yorkville Advisors Global, LP."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305115,"accession_number":"0001079973-23-000793","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-05-30T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Stockholders approve issuance of up to 20.4M shares upon conversion of $11.2M debentures to YA II PN","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Share issuance could exceed 20% of outstanding common stock and be priced below Nasdaq Minimum Price.","Third Amended and Restated Certificate of Incorporation approved: removes blank-check provisions, adds officer liability protection.","Charter also changes Delaware registered agent and makes conforming amendments.","Proposal to adjourn meeting was approved but not needed as quorum and votes were sufficient.","Vote results: 4,409,342 for share issuance, 1,171,332 against; 5,515,929 for charter amendment, 63,066 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305114,"accession_number":"0001079973-23-000735","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-05-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics begins using May 2023 investor presentation; no financial details disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Senior management will use the presentation for meetings with investors effective May 16, 2023.","Presentation available on company website; specific content not included in filing excerpt.","No new financial guidance, operational updates, or material events announced in the 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":324600,"accession_number":"0001079973-23-000326","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2023-03-13T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","8.01","9.01"],"status":"ready","headline":"Cardio Diagnostics enters $11.2M convertible debenture financing with Yorkville; receives initial $4.5M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Gross proceeds up to $11.2M from YA II PN, Ltd. (Yorkville); first tranche $5M debenture at 90% ($4.5M), second $6.2M upon SEC reg. effectiveness.","Convertible at lower of $5.00 or 92% of avg two lowest daily VWAPs over 7 days, floor $0.55; 12-month maturity, 0% interest (15% on default).","Proceeds to expand commercial adoption of PrecisionCHD and Epi+Gen CHD tests, launch new cardiovascular tests, and pursue payor coverage.","Company has no deposits at Silicon Valley Bank; all deposits except <$250K in a major money center bank."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":342441,"accession_number":"0001079973-22-001417","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cardio Diagnostics dismisses auditor MaloneBailey, appoints Prager Metis CPAs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed MaloneBailey as independent auditor on November 9, 2022; no disagreements or reportable events in prior periods.","Engaged Prager Metis CPAs as new independent registered public accounting firm for year ending December 31, 2022.","Prior MaloneBailey audit reports contained no adverse opinion or qualification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":342440,"accession_number":"0001079973-22-001382","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-10-31T23:59:59+00:00","items":["3.01","1.01","2.01","5.02","9.01","4.01","3.03","5.01","5.03","5.06","5.07","7.01"],"status":"ready","headline":"Cardio Diagnostics completes SPAC merger with Mana Capital; begins trading as CDIO, CDIOW","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Mana stockholders approved merger on Oct 25; Business Combination closed same day, Legacy Cardio becomes subsidiary.","6,465,452 Mana shares redeemed for $65.3M ($10.10/share); 9.5M shares outstanding post-closing.","Legacy Cardio stockholders (72.8% ownership) received ~6.9M shares; Sponsor holds 17.1% (1.625M shares).","Earnout up to 1M additional shares if stock price reaches $12.50-$20.00 targets over 4 years.","Common stock and warrants now trade on Nasdaq under CDIO and CDIOW; lock-up on ~5.2M shares for 6 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359160,"accession_number":"0001079973-22-001157","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-09-23T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"Mana Capital extends business combo deadline to Oct 26, 2022 with $216,667 loan from Cardio","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second one-month extension from Sept 26 to Oct 26, 2022, with up to 12 extensions permitted.","Cardio Diagnostics loaned $216,667 to Mana, deposited into trust account to fund the extension.","Promissory note issued to Cardio in the principal amount of $216,667.","Extension is part of the May 27, 2022 Merger Agreement for the planned business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359159,"accession_number":"0001079973-22-001136","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-09-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardio Diagnostics secures U.S. patent for cardiovascular disease detection technology","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["U.S. Patent No. 11,414,704 issued by USPTO to University of Iowa Research Foundation (UIRF), exclusively licensed to Cardio Diagnostics.","Patent covers compositions and methods for detecting predisposition to cardiovascular disease; co-invented by Cardio founders/CEO Meesha Dogan and CMO Robert Philibert.","The patent technology is used in Cardio's flagship product Epi+Gen CHD, a three-year symptomatic CHD risk assessment test introduced in 2021.","Cardio Diagnostics is merging with Mana Capital Acquisition Corp. (Nasdaq: MAAQU) in a previously announced business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359158,"accession_number":"0001079973-22-001114","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-09-15T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Mana Capital and Cardio Diagnostics Amend Merger Agreement to Increase Incentive Plan Shares and Provide Equity to UIRF","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment dated September 15, 2022 increases shares reserved under Cardio Diagnostics Holdings 2022 Incentive Plan to 3,265,516.","Upon closing, University of Iowa Research Foundation to receive 1% of aggregate merger consideration as common stock of Mana Capital.","Amendment modifies treatment of Company Equity Rights and adjusts Exchange Ratio definition in the Merger Agreement.","Other terms of the original Merger Agreement dated May 27, 2022 remain in full force and effect.","Business combination still subject to stockholder approval and customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359157,"accession_number":"0001079973-22-001040","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-08-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Mana Capital provides investor presentation for proposed Cardio Diagnostics merger","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Investor presentation first made available on August 26, 2022, for the business combination with Cardio Diagnostics.","Merger Agreement entered May 27, 2022; Cardio to become wholly owned subsidiary of Mana, renamed Cardio Diagnostics Holdings Inc.","Presentation will be used to solicit stockholder approval; Form S-4 proxy/prospectus filed with SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359156,"accession_number":"0001079973-22-001032","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-08-25T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"Mana Capital extends SPAC deadline to Sept 26 with $216,667 loan from Cardio Diagnostics","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Extended deadline to complete initial business combination from Aug 26 to Sept 26, 2022.","Cardio Diagnostics loaned $216,667 ($0.033/share) to fund the extension, deposited into trust.","Mana issued a promissory note to Cardio for the $216,667 loan amount.","This is the first of up to twelve one-month extensions permitted under governing docs.","Extension supports the proposed merger with Cardio Diagnostics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377963,"accession_number":"0001079973-22-000718","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-05-31T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Mana Capital SPAC to merge with Cardio Diagnostics in deal valuing target at $75M base","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cardio stockholders to receive shares of Mana Capital common stock valued at $10.00/share; base consideration $75M.","Additional earnout up to 1M shares if stock price reaches $12.50, $15.00, $17.50, $20.00 thresholds.","Closing conditions include Mana stockholder approval, Nasdaq listing, minimum $5M net tangible assets, and $4.5M private placement.","Expected closing Q3/Q4 2022; outside date Dec 23, 2022; Cardio pays $3M breakup fee in certain termination scenarios.","Post-closing board: six directors designated by Cardio, one by Mana; executive officers become Cardio's officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":396296,"accession_number":"0001079973-22-000098","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-01-25T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Mana Capital Acquisition Corp. switches auditor from Marcum to MaloneBailey","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Marcum Bernstein Pinchuk as auditor effective January 19, 2022, and engaged MaloneBailey same day.","Former auditor's reports had no adverse opinions except a going concern note that was subsequently resolved.","No disagreements or reportable events occurred during the engagement period.","Audit committee approved the change; former auditor provided letter to SEC agreeing with disclosure.","MaloneBailey will audit financial statements for the year ending December 31, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":396295,"accession_number":"0001079973-22-000044","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2022-01-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Mana Capital Acquisition Corp. units separate into stock, warrants, rights starting Jan 14, 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Holders of the 6,500,000 IPO units may elect to separate components starting January 14, 2022.","Each unit comprises one common share, half a warrant, and one right to receive 1/7 of a share at business combination.","Separated common stock trades under 'MAAQ', warrants under 'MAAQW', rights under 'MAAQR' on Nasdaq.","Units not separated continue to trade under symbol 'MAAQU'."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415328,"accession_number":"0001079973-21-001196","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2021-12-06T23:59:59+00:00","items":["3.02","8.01","9.01"],"status":"ready","headline":"Mana Capital Acquisition Corp. closes IPO and partial over-allotment, $65M in trust","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 6,200,000 units at $10.00/unit, gross proceeds of $62,000,000.","Private placement of 2,500,000 warrants to sponsor at $1.00/warrant, gross $2,500,000.","Underwriters partially exercised over-allotment: 300,000 additional units at $10.00, gross $3,000,000.","Sponsor issued 75,000 common shares in connection with over-allotment exercise.","Total trust proceeds of $65,000,000 from IPO, private placement, and over-allotment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415327,"accession_number":"0001079973-21-001182","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2021-12-03T23:59:59+00:00","items":["3.02","8.01","9.01"],"status":"ready","headline":"Mana Capital Acquisition Corp. closes IPO and private placement, raising $64.5M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 6.2M units at $10 each generated gross proceeds of $62M.","Private placement of 2.5M warrants at $1 each to sponsor raised $2.5M.","Total of $62M placed in trust account at J.P. Morgan Chase with Continental Stock Transfer as trustee.","Underwriters partially exercised over-allotment for 300K additional units ($3M); 75K shares issued to sponsor.","SPAC has 9–21 months to complete a business combination; no operations yet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415326,"accession_number":"0001553350-21-001109","cik":1870144,"company_name":"Cardio Diagnostics Holdings, Inc.","ticker":"CDIO","form_type":"8-K","filed_at":"2021-11-26T23:59:59+00:00","items":["1.01","3.02","5.03","8.01","9.01"],"status":"ready","headline":"Mana Capital Acquisition Corp. closes $62M IPO and $2.5M private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $62M from IPO of 6.2M units at $10.00 each; units trade on Nasdaq under MAAQU.","Additional $2.5M from private sale of 2.5M warrants to sponsor at $1.00 each.","Total $62M placed in trust account; company has 9-21 months to complete initial business combination.","Focus on targets in healthcare, technology, green economy, consumer products in NA, Europe, Asia.","Underwriters granted 45-day option to purchase up to 930,000 additional units for over-allotments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5179070.621468927,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}